• Something wrong with this record ?

Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy

A. Di Martino, V. Sedlarik,

. 2014 ; 474 (1-2) : 134-45. [pub] 20140812

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15031908

The aim of this work was to investigate the potential of an amphiphilic system comprising chitosan-grafted polylactide and carboxyl-functionalized polylactide acid as a carrier for the controlled release and co-release of two DNA alkylating drugs: doxorubicin and temozolomide. Polylactide and carboxyl-functionalized polylactide acid were obtained through direct melt polycondensation reaction, using methanesulfonic acid as a non-toxic initiator, and subsequently these were grafted to the chitosan backbone through a coupling reaction, utilizing 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide as a condensing agent. ATR-FTIR analysis and conductometric titration confirmed that a reaction between CS and PLA, PLACA2% and PLACA5% occurred. Chitosan-grafted-polylactide and polylactide-citric acid nanoparticles were prepared via the polyelectrolyte complex technique, applying dextran sulphate as a polyanion, and loaded with doxorubicin and temozolomide. The diameter of particles, ζ-potential and their relationship to temperature and pH were analysed in all formulations. Encapsulation, co-encapsulation efficiency and release studies were conducted in different physiological simulated environments and human serum. Results showed the continuous release of drugs without an initial burst in different physiological media.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031908
003      
CZ-PrNML
005      
20151013104549.0
007      
ta
008      
151005s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2014.08.014 $2 doi
035    __
$a (PubMed)25124059
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Di Martino, Antonio $u Polymer Centre, Faculty of Technology, Tomas Bata University in Zlin, nam. T.G. Masaryka 275, 76272 Zlin, Czech Republic; Centre of polymer systems, University Institute, Nad Ovčírnou 3685, 76001 Zlin, Czech Republic.
245    10
$a Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy / $c A. Di Martino, V. Sedlarik,
520    9_
$a The aim of this work was to investigate the potential of an amphiphilic system comprising chitosan-grafted polylactide and carboxyl-functionalized polylactide acid as a carrier for the controlled release and co-release of two DNA alkylating drugs: doxorubicin and temozolomide. Polylactide and carboxyl-functionalized polylactide acid were obtained through direct melt polycondensation reaction, using methanesulfonic acid as a non-toxic initiator, and subsequently these were grafted to the chitosan backbone through a coupling reaction, utilizing 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide as a condensing agent. ATR-FTIR analysis and conductometric titration confirmed that a reaction between CS and PLA, PLACA2% and PLACA5% occurred. Chitosan-grafted-polylactide and polylactide-citric acid nanoparticles were prepared via the polyelectrolyte complex technique, applying dextran sulphate as a polyanion, and loaded with doxorubicin and temozolomide. The diameter of particles, ζ-potential and their relationship to temperature and pH were analysed in all formulations. Encapsulation, co-encapsulation efficiency and release studies were conducted in different physiological simulated environments and human serum. Results showed the continuous release of drugs without an initial burst in different physiological media.
650    _2
$a chitosan $x aplikace a dávkování $x chemie $7 D048271
650    _2
$a dakarbazin $x aplikace a dávkování $x analogy a deriváty $x chemie $x terapeutické užití $7 D003606
650    _2
$a doxorubicin $x aplikace a dávkování $x chemie $x terapeutické užití $7 D004317
650    12
$a lékové transportní systémy $7 D016503
650    _2
$a lidé $7 D006801
650    _2
$a kyselina mléčná $x aplikace a dávkování $x chemická syntéza $x chemie $7 D019344
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a molekulární struktura $7 D015394
650    _2
$a nanočástice $x aplikace a dávkování $x chemie $7 D053758
650    _2
$a velikost částic $7 D010316
650    _2
$a polymery $x aplikace a dávkování $x chemická syntéza $x chemie $7 D011108
650    _2
$a povrchové vlastnosti $7 D013499
650    _2
$a povrchově aktivní látky $x aplikace a dávkování $x chemie $7 D013501
650    _2
$a teplota $7 D013696
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sedlarik, Vladimir $u Centre of polymer systems, University Institute, Nad Ovčírnou 3685, 76001 Zlin, Czech Republic. Electronic address: sedlarik@ft.utb.cz.
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 474, č. 1-2 (2014), s. 134-45
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25124059 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151013104738 $b ABA008
999    __
$a ok $b bmc $g 1092784 $s 915034
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 474 $c 1-2 $d 134-45 $e 20140812 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
LZP    __
$a Pubmed-20151005

Find record

Citation metrics

Archiving options